Solange Heller RS

Language: Spanish
References: 7
Page: 242-243
PDF size: 70.34 Kb.

Text Extraction

No abstract

REFERENCES

1. Gremse D. Gastroesophageal reflux disease in children: an overview of pathophysiology, diagnosis and treatment. J Pediatr Gastroenter Nutr 2002; 35: S297-S299.

2. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr 2000; 137: 800-7.

3. Tolia V, Fitzgerald J, Hassall E, Huang B, et al. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 2002; 35: S300-S307.

4. Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs 2003; 5(1): 25-40.

5. Litalien C, Theoret Y, Faure C. Pharmocokinetics of proton pump inhibitors in children. Clin Pharmacokinet 2005; 44(5): 441-66.

6. Dammann HG. Pantoprazoles in pediatric patients with peptic ulcer and reflux esophagitis. Med Klin 1998; 7-9.

7. Madrazo-de la Garza A, Dibildox M, Vargas A, et al. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children. H Pediatr Gastroenter Nutr 2003; 36: 261-5.